Development of a selective androgen receptor degrader (SARD) for treatment of castration-resistant prostate cancer

被引：1
|
作者：
Yao, ZhongKe [1 ]
Wardell, Suzanne [2 ]
Spasojevic, Ivan [2 ]
Norris, John [2 ]
Katzenellenbogen, John [1 ]
McDonnell, Donald [2 ]
Josan, Jatinder S. [1 ]
机构：
[1] Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA
[2] Duke Univ, Sch Med, Durham, NC 27706 USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-1805
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1805
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Discovery of a selective androgen receptor degrader (SARD) for treatment of castration-resistant prostate cancer
    Yao, Zhong-Ke
    Wardell, Suzanne
    Spasojevic, Ivan
    Norris, John
    Katzenellenbogen, John
    McDonnell, Donald
    Josan, Jatinder
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [2] Selective androgen receptor degrader (SARD) to overcome antiandrogen resistance in castration-resistant prostate cancer
    Wu, Meng
    Zhang, Rongyu
    Zhang, Zixiong
    Zhang, Ning
    Li, Chenfan
    Xie, Yongli
    Xia, Haoran
    Huang, Fangjiao
    Zhang, Ruoying
    Liu, Ming
    Li, Xiaoyu
    Cen, Shan
    Zhou, Jinming
    ELIFE, 2023, 12
  • [3] Androgen Receptor Signaling in the Development of Castration-Resistant Prostate Cancer
    Feng, Qin
    He, Bin
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [4] Spironolactone: A selective androgen receptor modulator in castration-resistant prostate cancer
    Barthelemy, Philippe
    Erdmann, Eva
    Duclos, Brigitte
    Bergerat, Jean Pierre
    Kurtz, Jean-Emmanuel
    Ceraline, Jocelyn
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [5] Discovery of a potent androgen receptor degrader for castration resistant prostate cancer
    Wang, C.
    Han, X.
    Fernandez-Salas, E.
    Qin, C.
    Xiang, W.
    Xu, T.
    Mceachern, D.
    Przybranowski, S.
    Foster, C.
    Bai, L.
    Lv, J.
    Huang, L.
    Wang, S.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E36 - E36
  • [6] Androgen Receptor Antagonists in Castration-Resistant Prostate Cancer
    Rathkopf, Dana
    Scher, Howard I.
    CANCER JOURNAL, 2013, 19 (01): : 43 - 49
  • [7] Development of Androgen Receptor Antagonists with Promising Activity in Castration-Resistant Prostate Cancer
    Shen, Howard C.
    Balk, Steven P.
    CANCER CELL, 2009, 15 (06) : 461 - 463
  • [8] Enzalutamide, an oral androgen receptor inhibitor for treatment of castration-resistant prostate cancer
    Sternberg, Cora N.
    FUTURE ONCOLOGY, 2019, 15 (13) : 1437 - 1457
  • [9] Targeting the androgen receptor in metastatic castration-resistant prostate cancer
    Aragon-Ching, Jeanny B.
    FUTURE ONCOLOGY, 2014, 10 (03) : 329 - 332
  • [10] Androgen receptor (AR) aberrations in castration-resistant prostate cancer
    Waltering, Kati K.
    Urbanucci, Alfonso
    Visakorpi, Tapio
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 360 (1-2) : 38 - 43
12345